Adalimumab/etanerceptAutoimmune renal disorders: 3 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2014年 / 1528卷 / 1期

关键词：

D O I：

10.1007/s40278-014-5023-z

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：16 / 16

相关论文

共 50 条

[41] Adalimumab/etanerceptMyositis, polymyositis and dermatomyositis: 3 case reports
Reactions Weekly, 2016, 1586 (1) : 24 - 24
[42] Adalimumab/infliximabHerpes simplex encephalitis: 3 case reports
Reactions Weekly, 2009, 1282 (1) : 8 - 8
[43] Adalimumab/etanercept/tocilizumabVarious toxicities: 3 case reports
Reactions Weekly, 2023, 1982 (1) : 19 - 19
[44] Adalimumab/etanercept/secukinumabVarious toxicities: 3 case reports
Reactions Weekly, 2023, 1953 (1) : 16 - 16
[45] Acitretin/adalimumab/ciclosporinLack of efficacy: 3 case reports
Reactions Weekly, 2023, 1980 (1) : 16 - 16
[46] Adalimumab/infliximabAlopecia and psoriasiform plaques: 3 case reports
Reactions Weekly, 2011, 1347 (1) : 7 - 7
[47] Adalimumab/etanercept/infliximabKeratoderma blenorrhagicum: 3 case reports
Reactions Weekly, 2008, 1212 (1) : 5 - 5
[48] Adalimumab/certolizumab pegolVarious toxicities: 3 case reports
Reactions Weekly, 2018, 1683 (1) : 30 - 30
[49] Adalimumab/infliximab/secukinumabActive tuberculosis: 3 case reports
Reactions Weekly, 2022, 1926 (1) : 19 - 19
[50] Adalimumab/infliximabOral lichen planus: 3 case reports
Reactions Weekly, 2015, 1568 (1) : 19 - 19

← 1 2 3 4 5 →